Identity
- Trade Name
- THERA-Trainer bemo FDA UDI
- Generic Name
- Continuous passive motion joint exerciser FDA UDI
- Model / Reference
- 01.XX.XX FDA UDI
Identifiers
- Primary DI / UDI-DI
- 04041925002812 FDA UDI
- FDA Product Code
- BXB FDA UDI
- GMDN Term
- Continuous passive motion joint exerciser FDA UDI
Classification
- Device Class
- Class I FDA UDI
- Regulation Number
- 890.5380 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
Yes
FDA UDI
Lot / Batch Number
No
FDA UDI
Serial Number
Yes
FDA UDI
Expiration Date
No
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Continuous passive motion joint exerciser
THERA-Trainer bemo by medica Medizintechnik GmbH — Class I — MDR, FDA UDI — listed in FDA GUDID, EUDAMED — regulatory data on deviCERTS
Similar devices
Also classified as Continuous passive motion joint exerciser.
- rebless — H ROBOTICS INC. · Class I
- CHATTANOOGA — DJO, LLC · Class I
- rebless — H ROBOTICS INC. · Class I
- EZ Stretch — FULL RANGE REHAB LLC · Class I
- rebless — H ROBOTICS INC. · Class I
- rebless — H ROBOTICS INC. · Class I
- rebless — H ROBOTICS INC. · Class I
- rebless (Model: RHDB) — H ROBOTICS INC. · Class II
Authorization Coverage (2 countries)
Regulatory Authorizations
European Union Unknown
MDR
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| EUDAMED | European Union | MDR | — | Class I | Unknown |
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class I | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- medica Medizintechnik GmbH
Sources (2)
- FDA UDI f47e057a-a9bb-469c-8bdd-11aeb394d27b 32 fields · synced Jun 18, 2026
- EUDAMED 1 fields · synced Jun 3, 2026